Stem cells derived from the developing and adult brain (neural stem cells; NSCs) and cell populations derived from glioblastoma (GBM) tumors have caught special attention due to the need for new approaches in diagnosis, treatment, and possible cures for diseases of the nervous system [3]. GBM is an aggressive type of nervous system tumor with a mean survival time of 12-14 months, and the survival time has remained low in spite of major efforts [4] . At least one subpopulation of progenitors with stem cell-like properties can be derived from GBM tumors, and these cells are referred commonly to as glioblastoma-derived stem cell-like cells (GSCs) [5]. GSCs seem to escape conventional irradiation treatment, chemotherapy, and surgery [4] , and it is therefore urgent to develop novel approaches for reliable detection of these and other cell types in GBM. While genetic approaches have proven successful in identifying and deciphering progenitors and stem cells in the healthy nervous system Figure S3) . In order to check for cell-to-cell leakage of the molecules, cells separately stained with p-HTMI and p-HTE-Ser were mixed and sorted with FACS. Two distinct fluorescence peaks were obtained, showing that cross contamination of the molecules does not occur (Supplementary Figure S3) . Taken together, these results verify that p-HTMI selectively detects undifferentiated embryonic NSCs in vitro.
Small probes specific for a distinct biomolecule or structural element have proven useful for recording biological events. In this regard, luminescent conjugated oligoand polythiophenes (LCOs and LCPs) have been utilized as target-specific chameleons that change their emission depending on the structural motif of a distinct target molecule even in a complex environment such as tissue [1] . LCOs and LCPs contain a repetitive flexible thiophene backbone, and a conformational restriction of the thiophene rings upon interaction with a biomolecule leads to a distinct optical fingerprint from the dyes. Previously, chemically defined anionic pentameric LCOs have been reported as amyloid specific ligands for optical detection of pathogenic protein aggregates in vivo [2] .
Stem cells derived from the developing and adult brain (neural stem cells; NSCs) and cell populations derived from glioblastoma (GBM) tumors have caught special attention due to the need for new approaches in diagnosis, treatment, and possible cures for diseases of the nervous system [3] . GBM is an aggressive type of nervous system tumor with a mean survival time of 12-14 months, and the survival time has remained low in spite of major efforts [4] . At least one subpopulation of progenitors with stem cell-like properties can be derived from GBM tumors, and these cells are referred commonly to as glioblastoma-derived stem cell-like cells (GSCs) [5] . GSCs seem to escape conventional irradiation treatment, chemotherapy, and surgery [4] , and it is therefore urgent to develop novel approaches for reliable detection of these and other cell types in GBM. While genetic approaches have proven successful in identifying and deciphering progenitors and stem cells in the healthy nervous system [6] , simple and reproducible techniques to rapidly identify and detect live NSCs and GBM cells without invasive or genetic modulation are desirable [7] . Most commonly, either antibodies or tools like green fluorescent protein (GFP) are used for detection of specific stem cell types, but these modes have several limitations for detection of live cells as they often are time consuming, require secondary amplification, and/or manipulation of the cells and/or organism.
Herein, we investigate the use of a library of LCOs with distinct side-chain functionalization as molecular probes for specific identification and detection of NSCs and GBM-derived cells in real time.
In order to characterize the library of LCOs in a NSC context, we used several very well-established differentiation protocols to generate a variety of cell types from NSCs derived from embryonic rat cortices to compare with the undifferentiated cells.
This NSC protocol, based on fibroblast growth factor 2 (FGF2) treatment, is wellcharacterized and widely used [8] and has been shown to contain of >>99% cells with ability to differentiate into neurons, astrocytes, and oligodendrocytes [8a,9] .
Interleukin-6-related cytokines such as the extrinsic factor ciliary neurotrophic factor (CNTF) induces astrocytic differentiation, fetal bovine serum (FBS) induces mesenchymal differentiation (smooth muscle cell-like), and a combination of BMP4/Wnt3a induces neuronal and astrocytic differentiation [10] . In a screen with various LCO libraries, we identified p-HTMI (Scheme 1, Figure 1a , Supplementary Figure S1 ) as a potential marker for NSCs. Within 10 minutes after application of p-HTMI by simply pipetting into the cell culture medium, fluorescence at a wavelength common to green fluorescent proteins was generated in undifferentiated embryonic rat NSCs (Figure 1b) . Two-photon microscopy revealed a strong fluorescent signal accumulated in the cytoplasm of the cells, thus indicating the probe had efficiently Figure S1) ) previously reported to specifically detect amyloid structures [6b,11] , displayed no cell-specific signal in undifferentiated NSCs (data not shown).
As p-HTMI is functionalized with methylated imidazole moieties (Scheme 1 and Figure 1a ) resembling the side chain of histidine/histamine, we asked whether the specificity of the NSC staining was dependent on this distinct side chain functionalization. We therefore generated pentameric LCOs with imidazole moieties lacking the methylation, p-HTA-His and p-HTIm (Supplementary Figure S1 , see also Scheme 1 and Supplementary scheme 2). Interestingly, we found that these molecules did not detect the NSCs tested above (Figure 1c and data not shown), suggesting that the methylation of the imidazole moieties is a crucial factor regulating the efficiency and specificity of the detection. However, a previously reported polydispersed LCP with methylated imidazole moieties attached to all thiophene units, PTMI [12] (Supplementary Figure S1) did not stain the NSCs either, suggesting that the length of the thiophene backbone or the positioning of the methylated imidazole moieties are additional important parameters to obtain the selective staining of the NSCs. Figure S3) . In order to check for cell-to-cell leakage of the molecules, cells separately stained with p-HTMI and p-HTE-Ser were mixed and sorted with FACS. Two distinct fluorescence peaks were obtained, showing that cross contamination of the molecules does not occur (Supplementary Figure S3) . Taken together, these results verify that p-HTMI selectively detects undifferentiated embryonic NSCs in vitro.
We next wanted to test whether the observed p-HTMI staining was a result of the treatment of the cells rather than the NSC phenotype. We therefore used mouse embryonic stem cells (ESCs) or NSCs derived from these cells by using an established retinoic acid-based protocol clearly distinct from the NSC-expanding protocol used hitherto [13] . Intriguingly, while p-HTMI did only stain a small fraction of ESCs (Figure   2a ), we found staining similar to that of embryonic brain-derived NSCs in the ESCderived NSCs at similar efficiency (Figure 2b ). This result indicated that p-HTMI is labeling embryonic or embryonic-like NSCs and not cells cultured with a particular protocol. In addition, p-HTE-Ser labeled >90% of the ES cells but did not show any staining in the ESC-derived NSCs (Figure 2c and data not shown).
Glioblastoma (GBM) is a common and aggressive type of brain tumor in adult humans [4] . Rat C6 glioma can be considered as an experimental model system for studying GBM. C6 glioma cells do not normally respond efficiently to differentiationinducing factors, which was confirmed by our experiments (Figure 3a) . We therefore applied the protocol for embryonic rat NSCs to C6 glioma cells to see if the differentiation potential could be affected. Grown in the presence of FGF2 on fibronectin coated plates and in N2 medium with supplements, C6 glioma cells grown as NSCs (referred to as C6DCs) formed uniform cultures of nestin-positive cells (Figure 3b) . In the C6DCs treated with CNTF, clear signs of increased astrocytic differentiation were detected (Figure 3b) , and valproic acid (VPA) induced differentiation into neuronal-like, TuJ1-positive cells (Figure 3b) as previously shown for embryonic rat NSCs [14] . In addition, the gene expression of gfap and Tubb3 was elevated upon CNTF and VPA treatment, respectively (Figure 3c) . Thus, rat C6 glioma cells grown in similar conditions as embryonic rat NSCs become responsive to external factors and obtain at least a subset of characteristics of neural stem cells.
Various studies have suggested that 1-4% of the conventionally cultured C6 glioma cells share characteristics of cancer stem cells [15] . We administered p-HTMI to regularly cultured C6 glioma cells and noted that this resulted in a staining of around 1-2% of the cells (Figure 2c) . In contrast, administration of p-HTE-Ser resulted in staining of >95% of the C6 glioma cells (Figure 2c) . We next stained C6DCs grown in the presence of FGF2 using p-HTMI or p-HTE-Ser. Surprisingly, the C6DCs stained with p-HTMI now displayed a strong fluorescent signal, while p-HTE-Ser did not stain any cells (Figure 2d ). FACS analysis confirmed these results and verified that a population of approximately 1% of regular C6 glioma cells is detected by p-HTMI (Figure 3d,e) . This experiment further validated the ability of p-HTMI to distinguish between cell types, as the vast majority of C6DCs and embryonic NSCs could be clearly distinguished from conventionally cultured C6 glioma cells (Figure 3f ).
As mentioned above, an advantage with previously developed polythiophene derivatives is that these have been shown to be applicable in vivo in patient material, for example when detecting amyloid aggregates in tissue from patients with Alzheimer's Disease [2b] . An in vivo application for p-HTMI could be of clinical importance for future development of use in surgical resection of GBM. To investigate whether p-HTMI could be applied also in an in vivo context, we transplanted either cells of a classic human GBM cell line (U-87MG; [16] ) or cells derived more recently from GBM patients [17] into the right striatum of mice as previously described [16] . The animals were monitored on a daily basis for neurological symptoms associated with tumor growth. The animals were sacrificed 5-7 weeks after transplantation of U-87MG and 16-24 weeks after transplantation of human GBM cells. Delivery of a terminal dose of avertin was followed by an injection of p-HTMI into the original site of glioma cell transplantation. The brains were then removed, cut by microtome, and the sections were investigated histologically in the microscope. The initial experiments using U-87MG cells did reveal a small (1-5%) population of human cells stained by injected p-HTMI (data not shown). Analysis of the mice with tumors derived from cells from GBM patients [17] The obtained results from the C6 glioma cell line in vitro and the orthotopic tumors in vivo prompted an investigation of whereas the human GBM cells detected by p-HTMI shared characteristics of so called GSCs. We therefore used three previously characterized cell lines (U3034MG, U3088MG, U3031MG) derived from human GBM expanded in vitro [17] from different individual patients with glioblastoma. Such patient-derived cells has been shown to contain a high proportion of tumor initiating cells (TICs), to stain positive for SOX2 and nestin, and have the ability to self-renew as well as differentiate into various neural cell fates [17] . FACS experiments demonstrated that p-HTMI reproducibly detected between 70-90% of the cells in these three cultures within 10 minutes from application of the molecule (Figure   5b ,c,e). To assess whether p-HTMI exerted any effect on the cell survival of these cells, we investigated the cell death in the cultures of the treated cells, but found no significant difference between control cultures and p-HTMI-treated cells when analyzing PI-staining and the number of Annexin V-positive cells by FACS (Figure 5a ).
We next aimed at elucidating the population of p-HTMI-positive cells detected in the GC cultures by comparison with antibodies previously discussed to detect stem-like cells from various sources of cancer. CD133 or prominin is an antigen expressed by various neural progenitor populations and it has been shown that depletion of CD133-positive cells from glioma cell populations decreases, but does not abolish, the tumor-initiating ability of transplanted glioma cells [4] . In the GC cultures examined, CD133 stained 20-70% of the cells in comparison to p-HTMI that stained 70-90% (Figure 5b,c) . To investigate whether the higher number of cells detected by p-HTMI was merely the result of a less specific labeling, we compared labeling of CD133 antibody and p-HTMI in the tumor cell line U-87MG, previously shown to contain a very small percentage of GSCs in cell culture [16] . The number of cells detected by CD133 antibody as well as p-HTMI was much lower in the U-87MG cultures, and in these cells, the number of cells detected by CD133 antibody was higher than that of p-HTMI (Figure 5d ). CD44 antibodies are under thorough investigation in various cancers for their ability to detect progenitor cells in vivo, but may not be suitable for use in vitro. Here, CD44 antibody detected basically all cells (>98%) in the three GC cultures as well as the U-87MG cell line and thus showed significantly less specificity than p-HTMI (Supplementary Figure S4, Figure 5b ,c,e, and data not shown).
CD271, or nerve growth factor receptor p75, has been reported to be expressed by various types of progenitor cells in many organs and in different tumor types. In accordance, it has been shown that CD271 antibody selectively detects neural progenitors in vitro and in vivo [18] . Intriguingly, it has been shown that CD271 antibody detects two subpopulations of cells in GBM, stem cell-like cells and the rapidly migrating cells [19] . We therefore pursued a double staining experiment with p-HTMI and CD271 antibody in GC cultures, and found by FACS that the cell populations in GC cultures stained by p-HTMI and CD271 are vastly overlapping 7, 63.0, 124.6, 126.8, 130.2, 132.1, 135.4, 135.9 .
Synthesis of 3
2 (328 mg, 0.975 mmol) was dissolved in DMF (3 mL) and the solution was cooled to solution was allowed to attain room temperature during 2h. DCM and brine were added and the organic phase was separated, washed twice with 1M HCl, dried, filtered, and concentrated. The slightly crude yellow product 3 (99%) was used without further purification in the next step. 1 H NMR (300 MHz, CDCl3/CD3OD 1:1) δ:
2.92 (t, J = 7.0 Hz, 4H), 3.74 (t, J = 7.0 Hz, 4H), 6.95 (s, 2H), 7.00 (s, 2H); 13 C NMR (75.5
MHz, CDCl3/CD3OD 1:1) δ: 32.7, 62.2, 111. 4, 127.4, 133.2, 133.4, 135.4, 137. 1.
Synthesis of 4
To a solution of 3 (463 mg, 0.937 mmol) in MeOH/toluene 1:1 (5 mL) were added 4, 28.8, 56.0, 63.6, 65.1, 80.5, 124.2, 125.0, 126.4, 126.9, 128.3, 131.1, 134.7, 135.5, 136.4, 136.7, 155.9, 171 .0.
Synthesis of p-HTE-Ser (7)
6 (0.048 g, 0.055 mmol) was dissolved in dichloromethane/TFA (4:1, 5 mL). After 2 h the solution was co-concentrated with toluene to give product 7 as red solid quantitively. 1 H NMR (300 MHz, DMSO-d6) δ 3.12 (t, 4H, J = 6.6 Hz), 3.69 (dd, 2H, J = 3.9, 11.6 Hz), 3.74 (dd, 2H, J = 4.3, 11.6 Hz), 3.93 (t, 3.9 Hz, 2H), 4.44 (t, J = 6.6 Hz, 4H), 7.11 (dd, J = 3.6, 5. (9) 5 (1.00 g, 1.24 mmol) was dissolved methylimidazole (4.75 mL) and DMF (1 mL). The mixture was heated at 75 ˚C for 4 hours and concentrated and co-concentrated with xylene to remove excess methylimidazole. Purification by gradient HPLC gave p-HTMI (9) 20.9, 29.6, 36.1, 49.1, 122.2, 124.0, 124.6, 125.7, 125.9, 126.3, 127.5, 128.8, 129.3, 130.8, 134.5, 134.9, 136.1, 136.3, 136.6, 141.4, 141.4 . O-(7-azabenzotriazol-1-yl)-N,N,N' ,N'-tetramethyluronium hexafluorophosphate (HATU), DMF; (iii) Et3SiH, TFA, DCM.
Synthesis of p-HTMI

Scheme 2. Reagents and conditions: (i) 1M NaOH, dioxane, H2O; (ii) H-His
(1-Trt)- OtBu, DIPEA,
Synthesis of p-HTA-His(1-Trt)-OtBu (11)
To a solution of p-HTAM (10) (93 mg, 0.167 mmol) in dioxane (2 mL) and H2O (0.5 mL) was added 1M NaOH (0.340 mL, 0.340 mmol). The solution was heated at 65 ˚C for 1 h, neutralized with 1M HCl, and the solvents were co-evaporated with toluene.
The residual was dissolved in DMF (3 mL) and H-His(1-Trt)-OtBu (302 mg, 0.666 mmol) and DIPEA (0.100 mL, 1.04 mmol) were added. The temperature of the solution was lowered to 0 ˚C and O-(7-azabenzotriazol-1-yl)-N,N,N',N'- tetramethyluronium hexafluorophosphate (HATU) (190 mg, 0.500 mmol) was added.
The solution was allowed to stir for 30 min at 0 °C and then for 4 h at room temperature. EtOAc, toluene and brine were added and the organic phase was 29.5, 37.4, 53.3, 75.3, 81.3, 119.3, 123.9, 124.7, 127.6, 127.9, 128.1, 129.9, 132.1, 132.2, 135.5, 136.1, 136.6, 137.0, 138.6, 142.4, 169.9, 170 .3.
Synthesis of p-HTA-His (12)
pHTA-His(1-Trt)-OtBu (11) (35 mg, 0.025 mmol) was dissolved in DCM (1 mL) and Et3SiH (0.035 mL, 0.414 mmol) was added. TFA (1 mL) was added and the solution was stirred for 3 h. The completeness of the reaction was validated by HPLC-MS.
Solvents were co-evaporated with toluene. Purification by HPLC-MS gave p-HTA-His (12) (b, 2H).
Cell culture
Rat embryonic neural stem cells (NSCs) and mouse embryonic stem cells were derived and cultured as previously described (Johe, Hazel et al. 1996 , Andersson, Duckworth et al. 2011 . Briefly, NSCs were harvested from the cerebral cortices of E15.5 embryos of timed pregnant Sprague-Dawley rats. Cells were mechanically dissociated and plated on previously coated tissue culture plates. NSCs and C6 (ATCC CCL-107) -derived stem cell-like cells were expanded in N2 medium supplemented with 10 ng/ml of FGF2 (R&D Systems) until 80% confluency. Animals were treated in accordance with institutional and national guidelines (ethical permits no. N310/05; N79/08; N284/11).
Staining of cells
In general, the LCOs were dissolved in deionized water to a final concentration of 1 mg/ml, and administered at a dilution of 1:500 (1:10-1:10 000 were tested), directly to each well and the detection was done after 10 min in a fluorescent microscope or FACS. p-HTMI generated fluorescence at a wavelength common to green fluorescent proteins.
Two-photon microscopy of NSCs stained with p-HTMI
The emission wavelength of p-HTMI was characterized in a two-photon microscope.
NSCs were grown in 35 mm plates (40 000 cells/plate) and treated with 10 ng/ml FGF2 for 48 hours. Prior to staining the cells, the medium was changed to DMEM:F12 medium without phenol red (Invitrogen) in order to eliminate background signals.
CellTracker (Invitrogen) was administered together with p-HTMI (1:500) in order to be able to find living cells, resulting in a double staining in red (CellTracker) and green (p-HTMI).
Immunocytochemistry
The plates were first rinsed once in PBS and then fixed in 10% formaldehyde for 20 min. The formaldehyde was aspirated and the plates were washed 3 times, 5 min each, in PBS/0.1% Triton-X 100. The plates were then incubated with respective primary antibody in PBS/0.1% Triton-X 100/ 1% BSA overnight at 4 °C. The samples were then washed 6 times, 5 min each, in PBS/0.1% Triton-X 100. Secondary antibodies (1:500) in PBS/0.1% Triton-X 100/1% BSA were incubated with the samples at room temperature for 1 h. The samples were then washed 3 times in PBS and mounted with Vectashield containing DAPI. Fluorescent images were acquired using a Zeiss Axioskop2 coupled to an MRm (Zeiss) camera at 10x, 20x, and 40x magnifications with Axiovision software. The primary and secondary antibody sources and dilutions were as follows: mouse anti-Nestin from BD Biosciences Pharmingen (1:500), mouse monoclonal anti-Neuronal Class III β-Tubulin (TuJ1) from Nordic Biosite (1:500), mouse monoclonal anti-a-smooth muscle actin (SMA) from Sigma (1:1000), rabbit poly-clonal anti-CD133 from Invitrogen (1:500) and rabbit poly-clonal anti-glial fibrillary acidic protein (GFAP) from DAKO (1:500). Speciesspecific Alexa-488, Alexa-594-conjugated secondary antibodies were used as appropriate and were obtained from Molecular Probes (1:500).
RT-qPCR
Total RNA was extracted from cells using RNeasy (Qiagen) and contaminating DNA digested using RNase free DNase kit (Qiagen). cDNA was synthesized using 200 ng of total RNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems).
1:25 dilution of the cDNA was used for real-time PCR. Platinum SYBR Green qPCR Supermix UDG (Invitrogen) was used for real-time PCR analysis with the 7500 PCR system (Applied Biosystems). Primers (MWG Biotech) are available on request.
Staining of rat neural stem cells (NSCs)
Neural stem cells were plated in a 6-well plate (40 000 cells/well) in serum-free DMEM:F12 (Invitrogen) with supplements and 10 ng/ml FGF2 (R&D systems) for 24 h prior to further stimulation. Cells were then stimulated with 10 ng/ml FGF2, 10 ng/ml CNTF (R&D systems), 10% FBS (Invitrogen), 1 mM VPA (Sigma) or without added factors (N2 medium) for three days. Addition of soluble factors was carried out every 24 h, and media was changed every 48 h. The LCOs were dissolved in deionized water to a final concentration of 1 mg/ml, and administered at a dilution of 1:500, directly to each well and the detection was done after 10 min in a fluorescent microscope. p-HTMI generated fluorescence at a wavelength common to green fluorescent proteins. A strong green signal was obtained in undifferentiated immature stem cells, accumulated in the cytoplasm of the cells, whereas differentiated and more mature cells displayed a significantly lower or no signal.
Neural stem cells were also treated with 10 ng/ml BMP4 and 10 ng/ml Wnt3a (R&D Systems) for 14 days and then stained with p-HTMI.
Staining of rat C6 glioma
C6 (ATCC CCL-107) glioma is a rat cell line used to as a model system for glioma cells.
The cells were grown in DMEM medium (Invitrogen) supplemented with 10% FBS.
For the purpose of maintenance, the C6 glioma cells were grown in 75 cm 2 flasks.
Prior to experiments the cells were split and plated (40 000 cells/well) in a 6-well plate. HEK-293 (ATCC CRL-1573), COS-7 (ATCC CRL-1651), and CV-1 (ATCC CCL-70) fibroblast cell lines were cultured according to the supplier's recommendations.
Staining of rat C6 glioma cultured as NSCs
C6 glioma cells were cultured with the same protocol as for NSCs, on plates precoated with poly-L-ornithine and fibronectin and then grown in N2 medium with supplements. The cells were plated in a 6-well plate (40 000 cells/well) in serum-free DMEM:F12 (Invitrogen) with supplements and 10 ng/ml FGF2 (R&D systems) for 24 h prior to further stimulation. Cells were then stimulated with 10 ng/ml FGF2, 10 ng/ml CNTF (R&D systems), 10% FBS (Invitrogen), 1 mM VPA (Sigma) or without added factors (N2 medium) for three days. Addition of soluble factors was carried out every 24 h, and media was changed every 48 h. p-HTMI was administered, at a dilution of 1:500, directly to each well and the detection was done after 10 min in a fluorescent microscope. p-HTMI generated chemoluminescence at a wavelength common to green fluorescent proteins.
Two-photon microscopy of NSCs stained with p-HTMI
NSCs were grown in 35 mm plates (40 000 cells/plate) and were treated with 
